Plus Therapeutics, Inc.
(NASDAQ: PSTV)

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.

0.249 -

+0.010 (+4.18%)
Range 0.232 - 0.251   (8.19%)
Open 0.237
Previous Close 0.239
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 11,293,391
Value 2,101,651
Remark -
Delayed prices. Updated at 29 Jan 2026 09:15.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis